Viral vector delivery of neurotrophic factors for Parkinson's disease therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Viral vector delivery of neurotrophic factors for Parkinson's disease therapy
Authors
Keywords
-
Journal
EXPERT REVIEWS IN MOLECULAR MEDICINE
Volume 17, Issue -, Pages -
Publisher
Cambridge University Press (CUP)
Online
2015-05-13
DOI
10.1017/erm.2015.6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhanced Efficacy of the CDNF/MANF Family by Combined Intranigral Overexpression in the 6-OHDA Rat Model of Parkinson's Disease
- (2015) Óscar Cordero-Llana et al. MOLECULAR THERAPY
- Canonical BMP–Smad Signalling Promotes Neurite Growth in Rat Midbrain Dopaminergic Neurons
- (2014) Shane V. Hegarty et al. NEUROMOLECULAR MEDICINE
- AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model
- (2013) Xinmiao Ren et al. EXPERIMENTAL NEUROLOGY
- Gene therapy clinical trials worldwide to 2012 - an update
- (2013) Samantha L. Ginn et al. JOURNAL OF GENE MEDICINE
- Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
- (2013) A. P. Kells et al. JOURNAL OF NEUROSCIENCE
- BMP2 and GDF5 induce neuronal differentiation through a Smad dependant pathway in a model of human midbrain dopaminergic neurons
- (2013) Shane V. Hegarty et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy
- (2013) Raymond T Bartus et al. MOLECULAR THERAPY
- Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120)
- (2013) Christopher D. Herzog et al. NEUROBIOLOGY OF DISEASE
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- BMP-Smad 1/5/8 signalling in the development of the nervous system
- (2013) Shane V. Hegarty et al. PROGRESS IN NEUROBIOLOGY
- Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease
- (2013) Susanne Bäck et al. Brain and Behavior
- Molecular neurosurgery: vectors and vector delivery strategies
- (2012) Edward White BRITISH JOURNAL OF NEUROSURGERY
- Intranasal delivery of growth differentiation factor 5 to the central nervous system
- (2012) Leah R. Hanson et al. DRUG DELIVERY
- Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease
- (2012) Daniel J. Costello et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating “clinical proof-of-concept” for AAV-neurturin (CERE-120) in Parkinson's disease
- (2012) Raymond T. Bartus et al. NEUROBIOLOGY OF AGING
- -Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons
- (2012) M. Decressac et al. Science Translational Medicine
- Guided delivery of adeno-associated viral vectors into the primate brain
- (2011) Ernesto A. Salegio et al. ADVANCED DRUG DELIVERY REVIEWS
- Intranasal delivery of biologics to the central nervous system
- (2011) Jeffrey J. Lochhead et al. ADVANCED DRUG DELIVERY REVIEWS
- GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease
- (2011) M. Decressac et al. BRAIN
- CDNF Protects the Nigrostriatal Dopamine System and Promotes Recovery after MPTP Treatment in Mice
- (2011) Mikko Airavaara et al. CELL TRANSPLANTATION
- Neurotrophic factors for the treatment of Parkinson's disease
- (2011) Aideen M. Sullivan et al. CYTOKINE & GROWTH FACTOR REVIEWS
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease
- (2011) R Mark Richardson et al. MOLECULAR THERAPY
- Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease
- (2011) Raymond T. Bartus et al. NEUROBIOLOGY OF DISEASE
- Glial-derived neurotrophic factor gene transfer for Parkinson's disease: Anterograde distribution of AAV2 vectors in the primate brain
- (2011) Adrian P. Kells et al. NEUROBIOLOGY OF DISEASE
- Novel Platform for MRI-Guided Convection-Enhanced Delivery of Therapeutics: Preclinical Validation in Nonhuman Primate Brain
- (2011) R. Mark Richardson et al. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
- Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease
- (2010) Merja H. Voutilainen et al. EXPERIMENTAL NEUROLOGY
- The Genetics of Parkinson Disease
- (2010) Lynn M. Bekris et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo
- (2010) David B. O’Sullivan et al. JOURNAL OF NEURAL TRANSMISSION
- Transfection Techniques for Neuronal Cells
- (2010) D. Karra et al. JOURNAL OF NEUROSCIENCE
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors
- (2010) Xiaomin Su et al. MOLECULAR THERAPY
- Bioactivity of AAV2-neurturin gene therapy (CERE-120): Differences between Parkinson's disease and nonhuman primate brains
- (2010) Raymond T. Bartus et al. MOVEMENT DISORDERS
- Image-guided convection-enhanced delivery of GDNF protein into monkey putamen
- (2010) Francisco Gimenez et al. NEUROIMAGE
- Functional Effects of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Parkinsonian Rhesus Monkeys
- (2009) Jamie L. Eberling et al. HUMAN GENE THERAPY
- Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys
- (2009) Louisa C. Johnston et al. HUMAN GENE THERAPY
- Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys
- (2009) Xiaomin Su et al. HUMAN GENE THERAPY
- Optimized cannula design and placement for convection-enhanced delivery in rat striatum
- (2009) Dali Yin et al. JOURNAL OF NEUROSCIENCE METHODS
- Tight Long-term Dynamic Doxycycline Responsive Nigrostriatal GDNF Using a Single rAAV Vector
- (2009) Fredric P Manfredsson et al. MOLECULAR THERAPY
- Nigrostriatal rAAV-mediated GDNF Overexpression Induces Robust Weight Loss in a Rat Model of Age-related Obesity
- (2009) Fredric P Manfredsson et al. MOLECULAR THERAPY
- Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates
- (2009) Dali Yin et al. NEUROIMAGE
- The structure of the conserved neurotrophic factors MANF and CDNF explains why they are bifunctional
- (2009) Vimal Parkash et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Role of transforming growth factor-β superfamily signaling pathways in human disease
- (2008) Kelly J. Gordon et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Transgene Expression, Bioactivity, and Safety of CERE-120 (AAV2-Neurturin) Following Delivery to the Monkey Striatum
- (2008) Christopher D Herzog et al. MOLECULAR THERAPY
- Freeze-dried Tendon Allografts as Tissue-engineering Scaffolds for Gdf5 Gene Delivery
- (2008) Patrick Basile et al. MOLECULAR THERAPY
- Progress in Parkinson's disease—Where do we stand?
- (2008) André Toulouse et al. PROGRESS IN NEUROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search